Literature DB >> 2671139

Use of antibacterial agents in infections of the central nervous system.

D Thea1, M Barza.   

Abstract

The movement of drugs from the systemic circulation into the central nervous system is restricted by several factors, including the blood-brain and blood-CSF barriers, an active transport system that affects primarily the beta-lactam antibiotics, and the high degree of serum protein binding of certain agents. The functions of the blood-brain and blood-CSF barriers and of the active transport system are reduced but not abolished by inflammation. For most antimicrobial agents, the major determinant of passage aside from serum protein binding is the degree of lipid-solubility of the drug. The beta-lactam and aminoglycoside antibiotics and vancomycin penetrate the central nervous system relatively poorly, whereas chloramphenicol, metronidazole, the fluoroquinolones and trimethoprim-sulfamethoxazole fare better. Knowledge of the relative capacity of various drugs to penetrate the central nervous system after systemic administration may help the physician to choose an optimum regimen for the treatment of bacterial meningitis and brain abscess.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671139

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  12 in total

1.  Complications of Acute Otitis Media and Sinusitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

Review 2.  Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.

Authors:  R Nau; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  Non-specific immunostaining by a rabbit antibody against gustducin α subunit in mouse brain.

Authors:  Guoxiang Xiong; Kevin Redding; Bei Chen; Akiva S Cohen; Noam A Cohen
Journal:  J Histochem Cytochem       Date:  2014-11-19       Impact factor: 2.479

4.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

Review 5.  Anatomical barriers for antimicrobial agents.

Authors:  M Barza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

6.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; P Muth; G Mahr; S Menck; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

8.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

Review 9.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

10.  Penetration of fusidic acid into human brain tissue and cerebrospinal fluid.

Authors:  T Mindermann; W Zimmerli; Z Rajacic; O Gratzl
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.